| (+)-alpha-tocopherol | multiple interactions | ISO | RGD:1344212 | 6480464 | alpha-Tocopherol inhibits the reaction [Rotenone affects the localization of PARK7 protein] | CTD | PMID:16439141 |
| (S)-nicotine | multiple interactions | ISO | RGD:1552781 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PARK7 mRNA; more ... | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases response to substance | ISO | RGD:1552781 | 6480464 | PARK7 protein results in decreased susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | CTD | PMID:15784737 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:1552781 | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PARK7 mRNA]; more ... | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | ISO | RGD:1552781 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PARK7 mRNA | CTD | PMID:20230807 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | RGD:1344212 | 6480464 | Metribolone results in increased expression of PARK7 protein | CTD | PMID:17152098 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1552781 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PARK7 mRNA | CTD | PMID:21570461 |
| 4-phenylbutyric acid | increases expression | EXP | | 6480464 | 4-phenylbutyric acid results in increased expression of PARK7 protein | CTD | PMID:21372141 |
| 4-phenylbutyric acid | multiple interactions | ISO | RGD:1344212 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of PARK7 protein] | CTD | PMID:17459145 |
| 4-phenylbutyric acid | multiple interactions | ISO | RGD:1552781 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of PARK7 protein] | CTD | PMID:17459145 |
| 4-phenylbutyric acid | increases expression | ISO | RGD:1344212 | 6480464 | 4-phenylbutyric acid results in increased expression of PARK7 mRNA; more ... | CTD | PMID:21372141 |
| 4-phenylbutyric acid | multiple interactions | EXP | | 6480464 | [4-phenylbutyric acid results in increased expression of PARK7 protein] which results in decreased susceptibility to Hydrogen Peroxide; more ... | CTD | PMID:21372141 |
| 4-phenylbutyric acid | increases expression | ISO | RGD:1552781 | 6480464 | 4-phenylbutyric acid results in increased expression of PARK7 protein | CTD | PMID:21372141 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PARK7 mRNA | CTD | PMID:16483693 |
| amphetamine | affects response to substance | ISO | RGD:1552781 | 6480464 | PARK7 protein affects the susceptibility to Amphetamine | CTD | PMID:15784737 |
| astemizole | increases expression | EXP | | 6480464 | Astemizole results in increased expression of PARK7 mRNA | CTD | PMID:20221588 |
| bisphenol A | affects localization | ISO | RGD:1552781 | 6480464 | bisphenol A affects the localization of PARK7 protein | CTD | PMID:23037695 |
| bromobenzene | affects binding | EXP | | 6480464 | bromobenzene metabolite binds to PARK7 protein | CTD | PMID:17305373 |
| butyric acid | increases expression | ISO | RGD:1344212 | 6480464 | Butyric Acid results in increased expression of PARK7 protein; more ... | CTD | PMID:21372141 |
| butyric acid | increases expression | EXP | | 6480464 | Butyric Acid results in increased expression of PARK7 protein | CTD | PMID:21372141 |
| butyric acid | increases expression | ISO | RGD:1552781 | 6480464 | Butyric Acid results in increased expression of PARK7 protein | CTD | PMID:21372141 |
| cisplatin | decreases expression | ISO | RGD:1552781 | 6480464 | Cisplatin results in decreased expression of PARK7 mRNA | CTD | PMID:21151649 |
| clozapine | increases expression | ISO | RGD:1552781 | 6480464 | Clozapine results in increased expression of PARK7 mRNA | CTD | PMID:14647396 |
| cobalt dichloride | decreases expression | ISO | RGD:1344212 | 6480464 | cobaltous chloride results in decreased expression of PARK7 mRNA | CTD | PMID:19376846 |
| crocidolite asbestos | affects expression | ISO | RGD:1344212 | 6480464 | Asbestos, Crocidolite affects the expression of PARK7 mRNA | CTD | PMID:17331233 |
| diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of PARK7 mRNA | CTD | PMID:21968025 |
| dibutyl phthalate | decreases expression | ISO | RGD:1552781 | 6480464 | Dibutyl Phthalate results in decreased expression of PARK7 mRNA | CTD | PMID:21266533 |
| disodium selenite | increases expression | ISO | RGD:1344212 | 6480464 | Sodium Selenite results in increased expression of PARK7 mRNA | CTD | PMID:18175754 |
| glutathione | increases abundance | ISO | RGD:1344212 | 6480464 | PARK7 protein results in increased abundance of Glutathione | CTD | PMID:18331584 |
| haloperidol | increases expression | ISO | RGD:1552781 | 6480464 | Haloperidol results in increased expression of PARK7 mRNA | CTD | PMID:14647396 |
| hydralazine | multiple interactions | ISO | RGD:1344212 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of PARK7 mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | increases expression | ISO | RGD:1344212 | 6480464 | Hydrogen Peroxide results in increased expression of PARK7 protein | CTD | PMID:11811539 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [4-phenylbutyric acid results in increased expression of PARK7 protein] which results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:21372141 |
| hydrogen peroxide | decreases response to substance | ISO | RGD:1344212 | 6480464 | PARK7 protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:18377993 |
| lactacystin | decreases response to substance | ISO | RGD:1344212 | 6480464 | PARK7 protein results in decreased susceptibility to lactacystin | CTD | PMID:18331584 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in decreased expression of PARK7 protein] | CTD | PMID:22245093 |
| manganese atom | decreases expression | EXP | | 6480464 | Manganese results in decreased expression of PARK7 protein | CTD | PMID:20798247 |
| manganese(0) | decreases expression | EXP | | 6480464 | Manganese results in decreased expression of PARK7 protein | CTD | PMID:20798247 |
| manganese(II) chloride | multiple interactions | EXP | | 6480464 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [manganese chloride results in decreased expression of PARK7 protein]; more ... | CTD | PMID:22245093 |
| manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of PARK7 protein | CTD | PMID:20798247 PMID:22245093 |
| manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of PARK7 mRNA; more ... | CTD | PMID:22245093 |
| mercury atom | increases expression | ISO | RGD:1344212 | 6480464 | Mercury results in increased expression of PARK7 mRNA | CTD | PMID:16823088 |
| mercury(0) | increases expression | ISO | RGD:1344212 | 6480464 | Mercury results in increased expression of PARK7 mRNA | CTD | PMID:16823088 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1344212 | 6480464 | Acetylcysteine inhibits the reaction [Rotenone results in increased expression of PARK7 protein] | CTD | PMID:18377993 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1344212 | 6480464 | Acetylcysteine inhibits the reaction [Paraquat promotes the reaction [Quinones binds to PARK7 protein]] | CTD | PMID:20851755 |
| ouabain | affects response to substance | ISO | RGD:1552781 | 6480464 | PARK7 affects the susceptibility to Ouabain | CTD | PMID:16624565 |
| paracetamol | affects expression | ISO | RGD:1552781 | 6480464 | Acetaminophen affects the expression of PARK7 mRNA | CTD | PMID:17562736 |
| paraquat | increases expression | ISO | RGD:1344212 | 6480464 | Paraquat results in increased expression of PARK7 protein | CTD | PMID:11811539 PMID:11697128 |
| paraquat | increases response to substance | ISO | RGD:1552781 | 6480464 | PARK7 protein results in increased susceptibility to Paraquat | CTD | PMID:21300143 |
| paraquat | multiple interactions | ISO | RGD:1552781 | 6480464 | PARK7 protein affects the reaction [Paraquat results in increased cleavage of CASP3 protein]; more ... | CTD | PMID:21300143 |
| paraquat | multiple interactions | ISO | RGD:1344212 | 6480464 | Paraquat promotes the reaction [Quinones binds to PARK7 protein]; more ... | CTD | PMID:20851755 |
| paraquat | increases expression | ISO | RGD:1344212 | 6480464 | Paraquat results in increased expression of PARK7 protein | CTD | PMID:11697128 PMID:11811539 |
| paraquat | multiple interactions | ISO | RGD:1552781 | 6480464 | PARK7 gene mutant form affects the reaction [Paraquat affects the expression of NFE2L2 protein]; more ... | CTD | PMID:17823202 |
| paraquat | increases expression | ISO | RGD:1344212 | 6480464 | Paraquat results in increased expression of PARK7 protein alternative form | CTD | PMID:14662519 |
| phlorizin | increases expression | ISO | RGD:1552781 | 6480464 | Phlorhizin results in increased expression of PARK7 mRNA | CTD | PMID:22538082 |
| rotenone | multiple interactions | ISO | RGD:1344212 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of PARK7 protein] | CTD | PMID:17459145 |
| rotenone | decreases response to substance | EXP | | 6480464 | PARK7 protein results in decreased susceptibility to Rotenone | CTD | PMID:22898350 |
| rotenone | affects response to substance | ISO | RGD:1344212 | 6480464 | PARK7 protein affects the susceptibility to Rotenone | CTD | PMID:20940149 |
| rotenone | increases expression | ISO | RGD:1344212 | 6480464 | Rotenone results in increased expression of PARK7 protein | CTD | PMID:17459145 PMID:18377993 |
| rotenone | affects localization | ISO | RGD:1344212 | 6480464 | Rotenone affects the localization of PARK7 protein | CTD | PMID:18377993 PMID:16439141 |
| rotenone | decreases response to substance | ISO | RGD:1344212 | 6480464 | PARK7 protein results in decreased susceptibility to Rotenone | CTD | PMID:18331584 PMID:18377993 |
| rotenone | increases oxidation | EXP | | 6480464 | Rotenone results in increased oxidation of PARK7 protein | CTD | PMID:16439141 |
| rotenone | increases expression | ISO | RGD:1552781 | 6480464 | Rotenone results in increased expression of PARK7 protein | CTD | PMID:17459145 |
| rotenone | affects localization | EXP | | 6480464 | Rotenone affects the localization of PARK7 protein | CTD | PMID:16439141 |
| rotenone | affects localization | ISO | RGD:1552781 | 6480464 | Rotenone affects the localization of PARK7 protein | CTD | PMID:19063952 |
| rotenone | increases expression | ISO | RGD:1344212 | 6480464 | Rotenone results in increased expression of PARK7 protein | CTD | PMID:18377993 PMID:17459145 |
| rotenone | decreases response to substance | ISO | RGD:1552781 | 6480464 | PARK7 protein results in decreased susceptibility to Rotenone | CTD | PMID:18930142 |
| rotenone | affects response to substance | ISO | RGD:1552781 | 6480464 | PARK7 affects the susceptibility to Rotenone | CTD | PMID:16624565 |
| rotenone | multiple interactions | ISO | RGD:1552781 | 6480464 | 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of PARK7 protein] | CTD | PMID:17459145 |
| rotenone | increases expression | ISO | RGD:1344212 | 6480464 | Rotenone results in increased expression of PARK7 mRNA | CTD | PMID:18377993 |
| rotenone | affects localization | ISO | RGD:1344212 | 6480464 | Rotenone affects the localization of PARK7 protein | CTD | PMID:16439141 PMID:18377993 |
| rotenone | decreases response to substance | ISO | RGD:1344212 | 6480464 | PARK7 protein results in decreased susceptibility to Rotenone | CTD | PMID:18377993 PMID:18331584 |
| rotenone | multiple interactions | ISO | RGD:1344212 | 6480464 | Acetylcysteine inhibits the reaction [Rotenone results in increased expression of PARK7 protein] | CTD | PMID:18377993 |
| rotenone | multiple interactions | ISO | RGD:1344212 | 6480464 | alpha-Tocopherol inhibits the reaction [Rotenone affects the localization of PARK7 protein] | CTD | PMID:16439141 |
| silver atom | increases expression | ISO | RGD:1552781 | 6480464 | Silver results in increased expression of PARK7 mRNA | CTD | PMID:19429238 |
| silver(0) | increases expression | ISO | RGD:1552781 | 6480464 | Silver results in increased expression of PARK7 mRNA | CTD | PMID:19429238 |
| superoxide | multiple interactions | ISO | RGD:1552781 | 6480464 | PARK7 protein affects the reaction [Paraquat results in increased abundance of Superoxides] | CTD | PMID:21300143 |
| toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of PARK7 mRNA | CTD | PMID:21827849 |
| valproic acid | multiple interactions | ISO | RGD:1344212 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of PARK7 mRNA | CTD | PMID:17183730 |
| valproic acid | affects expression | ISO | RGD:1552781 | 6480464 | Valproic Acid affects the expression of PARK7 mRNA | CTD | PMID:17292431 |